Pharmacotherapy for the treatment of tardive dyskinesia in schizophrenia patients
Sign Up to like & getrecommendations! Published in 2017 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2017.1323874
Abstract: ABSTRACT Introduction: Tardive dyskinesia (TD) is an iatrogenic movement disorder most commonly observed in patients with psychotic disorders who are treated with dopamine blocking antipsychotic medications. Treatment options are limited, and recommendations for treatment are… read more here.
Keywords: pharmacotherapy treatment; treatment; treatment tardive; tardive dyskinesia ... See more keywords
Pharmacotherapy for the treatment of vaginal atrophy
Sign Up to like & getrecommendations! Published in 2019 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2019.1574752
Abstract: ABSTRACT Introduction: Despite its frequency, recognition and therapy of vulvovaginal atrophy (VVA) remain suboptimal. Wet mount microscopy, or vaginal pH as a proxy, allows VVA diagnosis in menopause, but also in young contraception users, after… read more here.
Keywords: pharmacotherapy treatment; treatment vaginal; treatment; breast cancer ... See more keywords
Pharmacotherapy for the treatment of obstructive hypertrophic cardiomyopathy
Sign Up to like & getrecommendations! Published in 2020 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2019.1702023
Abstract: ABSTRACT Introduction: Hypertrophic cardiomyopathy (HCM) is one of the most common genetic heart diseases and represents a leading cause of sudden cardiac death as well as a prevalent cause of heart failure and stroke. HCM… read more here.
Keywords: pharmacotherapy treatment; treatment; hypertrophic cardiomyopathy; hcm ... See more keywords
Established Tables and Emergent Huddles: Exploring the Processes of Participation Associated With the Policy Changes to Opioid Pharmacotherapy Treatment in Australia in the Context of COVID-19
Sign Up to like & getrecommendations! Published in 2022 at "Contemporary Drug Problems"
DOI: 10.1177/00914509221123001
Abstract: In this paper we document and analyze emergent participatory processes in drug policy, focusing on the relations between established modes of engagement and emergent participatory formats. We do this through analysis of a case example,… read more here.
Keywords: participatory; pharmacotherapy treatment; opioid pharmacotherapy; policy ... See more keywords